Clinion is an integrated eClinical Platform consisting of an Electronic Data Capture (EDC), Randomisation and Trial Supply Management (IWRS/RTSM), Patient Reported Outcomes (ePRO) and Clinical Trial Management Systems (CTMS).
Clinion IT Services is a technology company offering innovative software solutions in the life sciences and pharmaceutical industries since 2010. Our first product, Clinion is an integrated clinical trial solution for small and medium CROs, academic research organizations and pharmaceutical companies.
We envisage Clinion to be the integrated eClinical platform of choice for small and medium CROs, and academic and pharmaceutical organisations in the global market.
Clinion has more than 25 customers in India, including JSS Medical Research, CBCC GLOBAL Research and the Public Health Foundation of India (PHFI). We are in the process of establishing our presence in the European markets and started to work with our first pilot customers in the UK.
250+ clinical trials, 18+ years industry experience, 16+ therapeutic areas, 15+ FDA approved studies.
Clinion was recognised as the ‘Best Software Product – Mature Stage‘ at the HYSEA* Innovation Summit 2020.
*Hyderabad Software Enterprises Association
At Clinion, we are working hard on a solid pipeline of product improvements
Predictive analytics with risk based monitoring
Our vision is to incorporate AI and automation at every step of the clinical trial process. Predictive analytics to help with patient recruitment, risk based site monitoring, adverse event management, and improved data management.
Clinion’s Mobile app (iOS and android) is in its last stage of development and it will enable our customers to deploy study eCRF on mobile phones, aiding remote study sites in capturing data offline.
Smart and automated eTMF to reduce manual labor.
Virtual clinical trials
Clinion’s integrated solution with EDC, RTSM and ePRO makes it an ideal fit for conducting clinical trials remotely.
Clinion COVID-19 Program
We offer Clinion at a discounted price for all COVID-19 studies to help the fight against the coronavirus pandemic.
Clinion is already being used in over 15 COVID-19 studies across multiple sites with a total subject count of over 17,000. Now available at a discounted price for all COVID-19 studies.
Located in Hyderabad, India, Clinion’s team is led by pharmaceutical industry veterans and supported by clinical research experts and enterprise software engineers. We have more than 30 people working across departments including product development, research, software engineering, product development, sales, QA and technical support.